The short version of thymalfasin fits in a sentence. The long version — which is the one that helps — is below.
This page was last updated on 2026-05-16 and is reviewed periodically as new material appears.
The name itself causes confusion, because several unrelated thymic peptides share the thymosin label. Thymosin beta-4, for example, is a different molecule with different functions. Naming conventions in the literature also mix descriptive research terms with assigned nonproprietary names, so a reader should confirm which entity a given paper addresses. Clarifying that point is usually the first step in interpreting any claim about this peptide.
Thymosin alpha-1 is a short peptide of 28 amino acid residues first described in the 1970s as a component of thymic extracts. Its N-terminal residue carries an acetyl group, and the sequence is highly conserved across mammalian species. The peptide is not encoded as a standalone gene product; it is released by proteolytic cleavage from the N-terminus of prothymosin alpha, a larger acidic nuclear protein. That precursor relationship places it within a broader family of thymic and immune-associated peptides that have been studied for decades.
Thymosin alpha 1 is a short peptide of 28 amino acid residues that derives from the amino terminal region of a larger precursor protein known as prothymosin alpha. The peptide carries an acetyl group on its first residue and contains no disulfide bonds or carbohydrate chains. Its sequence is highly conserved across mammalian species, which is one reason laboratories treat it as a molecule with a defined and reproducible structure rather than a variable tissue extract. The name follows an early naming convention for thymus-derived fractions and does not imply that the peptide acts as a hormone in the classical endocrine sense.
Biologically, the peptide is studied mainly in the context of immune cell development and regulation. It is produced in the thymus and in several other tissues, and it appears to influence the maturation and activity of T cells and other immune populations. Laboratory work describes effects on cytokine production, on the balance between T cell subsets, and on the function of dendritic cells. Much of this evidence comes from cell culture and animal models, so the extent to which the same pathways operate in humans remains an open question.
Clinical interest has centered on chronic viral hepatitis, on immune restoration in various conditions, and on use as an adjuvant intended to improve responses to vaccines. Trials have reported mixed results, and regulatory status differs sharply between countries; in some places it is a prescription product, while elsewhere it is sold without an approved therapeutic indication. Because published studies vary widely in design, population, and endpoints, comparisons across them are difficult and no single conclusion covers the whole literature.
| Property | Value | Notes |
|---|---|---|
| Residue count | 28 amino acids | Acetyl group on the first residue |
| Approximate molecular mass | 3108 daltons | Calculated from the consensus sequence |
| Origin | Cleavage product of prothymosin alpha | Not encoded as a separate gene product |
| Primary research focus | Immune modulation | Studied in viral hepatitis and as a vaccine adjuvant |
| Common synonyms | Thymalfasin, Tα1, thymosin alpha 1 | Thymalfasin is the assigned nonproprietary name |
Recommended storage for the dry powder is a freezer near minus twenty degrees Celsius, kept desiccated and away from light. Once dissolved, the peptide is less stable and is usually held at two to eight degrees Celsius for short intervals or frozen for longer storage. Stability studies focus on the acetylated terminus and the disulfide linkage because those features define the intact molecule. Common degradation routes include cysteine oxidation, deamidation of asparagine or glutamine side chains, and slow formation of higher-molecular-weight species.
Identity and purity are usually checked by reverse-phase high-performance liquid chromatography, which separates the intact chain from truncated products, together with mass spectrometry for confirmation of the expected mass. Peptide mapping after enzymatic digestion and amino acid analysis add sequence-level evidence. Release testing also covers water content, residual solvents, and counter-ions, all of which influence measured mass and stability. Related-peptide limits are commonly expressed as a percentage of total peak area, with individual unspecified impurities held below a lower threshold.
The lyophilized peptide is a white to off-white powder that dissolves freely in water and in aqueous buffers near neutral pH. Because the molecule carries a net negative charge under physiological conditions, saline and phosphate solutions are the usual vehicles, while strongly acidic media are avoided. Stock solutions are commonly divided into small aliquots so that repeated freezing and thawing can be limited, since cycling may encourage aggregation. Solubility in organic solvents is poor and those solvents are seldom used as primary diluents.
Clinical research has examined the peptide in chronic hepatitis B and C, as a vaccine adjuvant, and in sepsis and oncology settings. Results across trials have been mixed, and several studies were small or conducted under differing protocols. Regulatory status varies by country, and the compound is not approved in every jurisdiction where it is studied. Evidence for any single indication should be read with attention to sample size and endpoint choice.
Thymosin alpha-1 is a 28-residue peptide first isolated from thymus tissue in the 1970s. It corresponds to the N-terminal portion of thymosin beta-4, from which it is cleaved in vivo. The peptide carries an acetyl group at its N-terminus, a modification that affects its charge and stability. Synthetic material produced by solid-phase peptide synthesis is chemically identical to the natural fragment and is the form used in research and clinical studies.
Laboratory work indicates that the peptide acts on cells of both the innate and adaptive immune systems. Reported effects include signalling through Toll-like receptors on dendritic cells, enhanced T-cell maturation, and increased natural killer cell activity. These actions are described largely from cell-culture and animal experiments, and the precise receptor-level events remain incompletely defined. Studies in humans have generally measured immune markers rather than a single defined molecular target. The resulting picture remains partly descriptive.
SumoPred-PLM or SUMOylation site Prediction using Protein Language Model - An AI deep learning utility to predict based on known biological rules around SUMO2 and SUMO3 binding in human proteins incorporating knowledge from a separate pretrained PLM tool developed previously in 2021 by Elnaggar et al. known as ProtT5-XL-UniRef50. Such collaboration between multidisciplinary AI tools is becoming common practice.
== Nanomaterials in articles, patents, and products == The quantitative analysis of nanomaterials showed that nanoparticles, nanotubes, nanocrystalline materials, nanocomposites, and graphene have been mentioned in 400,000, 181,000, 144,000, 140,000, and 119,000 ISI-indexed articles, respectively, by September 2018. As far as patents are concerned, nanoparticles, nanotubes, nanocomposites, graphene, and nanowires have been played a role in 45,600, 32,100, 12,700, 12,500, and 11,800 patents, respectively. Monitoring approximately 7,000 commercial nano-based products available on global markets revealed that the properties of around 2,330 products have been enabled or enhanced aided by nanoparticles. Liposomes, nanofibers, nanocolloids, and aerogels were also of the most common nanomaterials in consumer products. The European Union Observatory for Nanomaterials (EUON) has produced a database (NanoData) that provides information on specific patents, products, and research publications on nanomaterials.
== N == Robert Nalbandyan (1937–2002), Armenian protein chemist known for discovery of photosynthetic protein plantacyanin Sergey Nametkin (1976–1950), Russian organic chemist known the cracking of petrochemicals, and rearrangement of camphenes Louise Natrajan (PhD 2003), British chemist who ortks on actinide chemistry and luminescence spectroscopy Giulio Natta (1903–1979), Italian chemical engineer worked on high density polymers, 1963 Nobel Prize in Chemistry Costin Nenițescu (1902–1970), Romanian chemist who studied the oxidation of open-chain and aromatic hydrocarbons with chromic acid and chromic oxychloride Antonio Neri (1576–1614), Florentine priest, author of L’Arte Vetraria (The Art of Glass), the first general treatise on the systematics of glassmaking Walther Nernst (1864–1941), German physical chemist whose heat theorem led the way to the third law of thermodynamics, 1920 Nobel Prize in Chemistry John Alexander Reina Newlands (1837–1898), British analytical chemist, precursor of the periodic order of elements William Nicholson (1753–1815), British chemist and civil engineer, the first to achieve electrolysis Kyriacos Costa Nicolaou (born 1946), Cypriot-American chemist known for total synthesis of natural products Julius Nieuwland (1878–1936), Belgian and American prirest and chemist who worked on synthetic rubber Mathias Nilsson, Swedish physical and analytical chemist concerned with liquid NMR spectroscopy Alfred Nobel (1833–1896), Swedish chemist who invented dynamite and established the Nobel Prizes Ronald George Wreyford Norrish (1897–1978), British chemist known for flash photolysis and the Norrish reaction, 1967 Nobel Prize in Chemistry John Howard Northrop (1891–1987), American biochemist known for isolation, crystallization, and study of enzymes, proteins, and viruses; 1946 Nobel Prize in Chemistry Ryōji Noyori (born 1938), Japanese chemist, 2001 Nobel Prize in Chemistry for the study of chirally catalyzed hydrogenations Ralph Nuzzo (born 1954), American materials chemist known for work on the chemistry of materials, including processes that occur at surfaces and interfaces
Sources: en.wikipedia.org
=== Celebrity status === In 2008, Pudzianowski took part in the 7th season of Dancing with the Stars in his native Poland. He advanced to the final episode, but ultimately finished second, losing to actress Magdalena Walach. Pudzianowski was a contestant in the 1st season of the singing reality show Just the Two of Us in Poland. He was coupled with former Ich Troje singer Anna Wiśniewska.
Hyperthyroidism, associated with pretibial myxedema and exophthalmos. Pretibial myxedema can occur in 1–4% of patients with Graves' disease, a cause of hyperthyroidism. Hypothyroidism, including Hashimoto's thyroiditis.
=== Other causes === Atherosclerotic disease is not the only cause of myocardial infarction, but it may exacerbate or contribute to other causes. A myocardial infarction may result from a heart with a limited blood supply subject to increased oxygen demands, such as in fever, a fast heart rate, hyperthyroidism, too few red blood cells in the bloodstream, or low blood pressure. Damage or failure of procedures such as percutaneous coronary intervention (PCI) or coronary artery bypass grafts (CABG) may cause a myocardial infarction. Spasm of coronary arteries, such as Prinzmetal's angina may cause blockage.
=== Retirement: 1997–2005 === In 1997, the New Riders of the Purple Sage split up. Dawson retired from music and moved to Mexico to become an English teacher. By this time, Nelson had started his own David Nelson Band. There was a reunion performance in 2001. In 2002, the New Riders accepted a Lifetime Achievement Award from High Times magazine. On hand were a frail Dawson (suffering from emphysema), Nelson, Cage, Dryden and Torbert's widow Patti. The band performed "Panama Red" and "Lonesome LA Cowboy" with Peter Rowan as part of the celebration. In the spring of 2004, Cage sat in at several gigs with the David Nelson Band.
Sources: en.wikipedia.org
In 1899 Lore Rogers was offered a position as assistant bacteriologist at the New York State Agricultural Experiment Station, Geneva. The New York State Legislature had established the State Agricultural Experiment Station, which opened in 1882. It was no coincidence that two bacteriologists overlapped at Wisconsin and arrived at the experiment station in 1899. Harry Alexis Harding had been an undergraduate and graduate student at Wisconsin under H. L. Russell (and would later earn a PhD at Cornell University). Harding, with his Wisconsin M.S. degree followed by study in Europe, was appointed chief dairy bacteriologist, and Lore would serve as assistant. The experiment station staff around 1900 included a superintendent, an animal industry specialist, two botanists, eight chemists, two bacteriologists, a dairy expert, three entomologists, three horticulturalists, an editor-librarian, and two clerk-stenographers. The two bacteriologists, Harry Harding, and Lore Rogers, collaborated on several reports on milk and cheese, with Harding listed as senior author. George A. Smith,"dairy expert" was another collaborator. Some station bulletins co-authored by Lore Rogers included "The Efficiency of a Continuous Pasteurizer at Different Temperatures" (1899), "Inspection of Babcock Milk Test Bottles" (1900), "Dairy Disagreeables Busy the Bacteriologists" (1900), and "Notes on Some Dairy Troubles" (1900).
The Israeli Ground Forces (Hebrew: זְרוֹעַ הַיַּבָּשָׁה, romanized: z'róa hibshá, lit. 'The Land Arm') are the army of the Israel Defense Forces (IDF). The current commander of the ground forces is Major General Nadav Lotan. An order from Defense Minister David Ben-Gurion on 26 May 1948 officially set up the Israel Defense Forces as a conscript army formed out of the paramilitary group Haganah, incorporating the militant groups Irgun and Lehi. The Ground Forces have served in all the country's major military operations—including the 1948 Arab–Israeli War, 1956 Suez Crisis, 1967 Six-Day War, 1973 Yom Kippur War, 1976 Operation Entebbe, 1982 Lebanon War, 1987–1993 First Intifada, 2000–2005 Second Intifada, 2006 Lebanon War, and the Gaza War (2008–09). While originally the IDF operated on three fronts—against Lebanon and Syria in the north, Jordan and Iraq in the east, and Egypt in the south—after the 1979 Egyptian–Israeli Peace Treaty, it has concentrated in southern Lebanon and the Palestinian territories, including the First and the Second Intifada. The Ground Forces uses several technologies developed in Israel such as the Merkava main battle tank, Achzarit armoured personnel carrier, the Iron Dome missile defense system, Trophy active protection system for vehicles, and the Galil and Tavor assault rifles. The Uzi submachine gun was invented in Israel and used by the Ground Forces until December 2003, ending a service that began in 1954.
== Description == The Liliaceae are characterised as monocotyledonous, perennial, herbaceous, bulbous (or rhizomatous in the case of Medeoleae) flowering plants with simple trichomes (root hairs) and contractile roots. The diversity of characteristics complicates any description of the family's morphology, having confused taxonomic classification for centuries. The diversity is also of considerable evolutionary significance, as some members emerged from shaded areas and adapted to a more open environment. Characteristics often vary by habitat, between shade-dwelling genera (such as Prosartes, Tricyrtis, Cardiocrinum, Clintonia, Medeola, Prosartes, and Scoliopus) and sun-loving genera. Shade-dwelling genera usually have broader leaves with smooth edges and net venation, and fleshy fruits (berries) with animal-dispersed seeds, rhizomes, and small, inconspicuous flowers. Meanwhile, genera native to sunny habitats usually have narrow, parallel-veined leaves, capsular fruits with wind-dispersed seeds, bulbs, and large, visually conspicuous flowers.
Timothy C. Bates (born 1963) is a professor of differential psychology at the University of Edinburgh. His research interests include the genetics of reading and spelling, intelligence, and personality.
1993/3083) Friendly Societies Act 1992 (Transitional and Consequential Provisions) Regulations 1993 (S.I. 1993/3084) Welfare of Animals at Markets (Amendment) Order 1993 (S.I. 1993/3085) Diseases of Animals (Approved Disinfectants) (Amendment) (No. 2) Order 1993 (S.I. 1993/3086) Civil Aviation (Route Charges for Navigation Services) (Second Amendment) Regulations 1993 (S.I. 1993/3098)
Sources: en.wikipedia.org
It is usually classified as an immunomodulatory peptide rather than a classical hormone. It derives from the larger protein prothymosin alpha and acts mainly on immune cells. The thymosin label covers a group of distinct peptides, so the naming can be misleading.
The two share a family name but have different sequences, sizes, and functions. Thymosin beta-4 is a 43-residue peptide associated with actin binding and cell migration. Thymosin alpha-1 is a 28-residue peptide linked mainly to immune signaling.
Thymalfasin is the assigned international nonproprietary name for the synthetic 28-residue peptide. Thymosin alpha-1 is the descriptive research name for the same molecule. Which term appears depends on the context and the regulatory document.
The name reflects an early convention for naming thymus-derived fractions. The peptide is characterized and measured as a defined molecule, and it does not operate through a single classical endocrine axis.